Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer
Clinical trial NCT03190265 · COMPLETED
Trial details
- NCT number
- NCT03190265
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-14
- Primary completion
- 2022-08-03
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.